Chronic wounds are a health problem that have devastating consequences for patients and contribute major costs to healthcare systems and societies. To understand the magnitude of this health issue, a systematic review was undertaken. Searches were conducted in MEDLINE, EMBASE, EBM Reviews and Cochrane library, CINAHL, EBSCO, PsycINFO, and Global Health databases for articles published between 2000 and 2015. Included publications had to target adults (≥18 years of age), state wound chronicity (≥3 weeks) and/or label the wounds as chronic, complex, hard-to-heal, or having led to an amputation. The review excluded studies that did not present data on generic health-related quality of life and/or cost data, case studies, randomized controlled trials, economic modeling studies, abstracts, and editorials. Extracted data were summarized into a narrative synthesis, and for a few articles using the same health-related quality of life instrument, average estimates with 95% confidence intervals were calculated. Thirty articles met the inclusion criteria. Findings revealed that health-related quality of life was lowest for physical pathologies, and based on average estimates were scores most inferior in the domain physical role for both patients with chronic wounds and for those with wound-related amputations. The cost burden was mainly attributed to amputations for patients also comorbid with diabetes, where the cost for hospitalization ranged from US$12,851 to US$16,267 (median) for this patient group. Patients with chronic wounds have poor health-related quality of life in general and wound-related costs are substantial. Development and implementation of wound management strategies that focus on increasing health-related quality of life and effectively reduce costs for this patient group are urgently needed.
CINAHL
Cumulative Index to Nursing and Allied Health Literature DRG Diagnosis-related group EBM Evidence-based medicine EQ-5D
EuroQol-5D EQ-5D VAS VAS EuroQol-5D Chronic wounds, hard-to-heal or difficult-to-heal wounds/ ulcers, are defined as wounds that do not heal properly during an amount of time that normally should be sufficient for healing. 1 There is no preestablished consensus for the duration of chronicity, 2 and the wounds are often managed as a comorbidity of other conditions. 3 Chronic wounds have significant humanistic and economic burdens, both at an individual (e.g., quality of life) 4 and a societal level (e.g., healthcare costs). 1, [5] [6] [7] The humanistic burden, often
Wound Rep Reg (2019) 27 114-125 © 2018 by the Wound Healing Society presented as HRQoL, reflects specific dimensions of health (e.g., physical and psychological), 8 and is assessed in health economic studies to understand and estimate the burden of patients suffering from a condition or disease. 8 Chronic wounds are also associated with major economic burdens, comprising direct (medical and health care costs) and indirect costs (productivity losses, e.g., sick leave and early retirement) to the society. 1, [5] [6] [7] Treatment costs for chronic wounds are substantial and are estimated to account for approximately 1-3% of the total healthcare expenditure in developed countries. 1, [5] [6] [7] However, this is probably an underestimation because more recent studies report even greater costs. 6 For example, Wales was estimated to have a chronic wound prevalence of 6% in the year 2012-2013, corresponding to 5.5% of National Health Service expenditure, 6 and in the United Kingdom as a whole, the cost associated with wound management was estimated to be £4.5 and £5.1 billion in 2012. 9 In the United States, it has been reported that over 6.5 million patients with wounds cost the health care system US$25 billion annually. 7 The humanistic and economic burden of chronic wounds is underappreciated and growing due to an aging population, and earlier development of chronic illnesses such as diabetes, etc. 7 A recent systematic review explored the cost-ofillness for chronic wounds but did not specify how chronicity in the included studies was defined, nor explored the humanistic burden, which is crucial to understand the magnitude of the problem. 10 No previous systematic review has assessed both the humanistic and economic burden of chronic wounds. This systematic review with a definition for chronicity (duration ≥3 weeks) aimed to explore the impact of chronic wounds on HRQoL for patients and their caregivers and to explore the economic impact of the condition measured as costconsequences to society.
MATERIALS AND METHODS

Search strategy and selection criteria
This systematic review followed the PRISMA statement, 11 and systematic searches were carried out in the MEDLINE, EMBASE, EBM Reviews and Cochrane library, Cumulative Index to Nursing and Allied Health Literature (CINAHL, EBSCO), PsycINFO, and Global Health databases during April 2016. 12 The search was limited to articles published between January 2000 and December 2015. Search strategies were created in collaboration with dermatology-and wound-specialist and medical research librarians. 12 Studies targeting adults ≥18 years of age having chronic wounds specified by wound duration (≥3 weeks), or labeled as chronic, complex, hard-to-heal or having led to an amputation were included. Wounds that failed to heal within 3 weeks were considered chronic, as ulcers not reducing in size after 4 weeks are probable to become chronic. 13 As there is no preestablished consensus for chronicity and when a wound generally is considered as chronic a duration of ≥3 weeks was deemed appropriate to capture hard-to-heal wounds across various wound etiologies. 2 HRQoL articles had to report data obtained from a generic instrument (e.g., 36-item Short-Form Health Survey , SF-12, SF-6D, and EuroQol-5D [EQ-5D]), and for economic burden studies, cost data had to be presented.
Only peer-reviewed, full-text publications in English were included. The review excluded large nonchronic wounds (e.g., surgical wounds and skin tumors that due to size and malignity require a longer time to heal), and solely diseasespecific HRQoL studies, case studies, randomized controlled trials, economic modeling studies, abstracts, or editorials.
The included publications were imported to Endnote X7©, and duplicates were removed. Two reviewers independently screened the titles and abstracts to identify studies with potential for inclusion, and full-text copies of relevant articles were obtained and assessed for eligibility for final inclusion. Discrepancies in assessment were resolved by discussion between the reviewers, with reasons for exclusion noted.
Data extraction
Data extraction was done independently by two reviewers and documented in extraction forms inspired by the Joanna Briggs Extraction Form for Economic Evaluations.
14 The methodological quality was assessed by using the Joanna Briggs Institute (JBI) Critical Appraisal Tool: Checklist for Prevalence studies, which is mainly developed for prevalence data but also applicable for quality of life data such as HRQoL, 15, 16 and Drummond and Jefferson's Checklist for Economic Evaluation 17 for cost articles. HRQoL-and cost data were reviewed separately and key findings were summarized. The results were presented as a descriptive narrative synthesis including pooled-analyses for HRQoL outcomes when homogeneity allowed (i.e., when data were uniform enough to enable comparisons).
Statistical analysis
No formal meta-analysis was performed due to the large heterogeneity (probably due to different kinds of wounds, severity, and method of evaluation, etc.) between studies. For HRQoL, weighted average with corresponding 95% confidence interval (CI) was calculated for SF-36 domains separately for chronic wounds and amputation groups. Weighted mean and corresponding standard deviation were calculated by
, respectively, where n i is the sample size of study group i, m i is the mean of study group i, s i is the standard deviation of study group i, and T is the number of studies. For missing standard deviation values corresponding to a SF-36 domain, we used largest available standard deviation in the group of studies to enable weighted standard deviations. 18 Subgroup analyses were conducted for chronic wounds (excluding amputation groups due to lack of control group and less than three studies in total) when control groups were present (see Supporting Information Figure S1 ). No formal statistical comparisons was performed for the subgroup analysis of SF-36 domain scores in order to avoid misleading conclusions as recommended in the Cochrane Handbook for systematic reviews. 19 A value of p < 0.05 was considered statistically significant and data analyses were conducted in Stata software version 14.0 (StataCorp LLC, College Station, Texas).
Currencies extracted from the included cost articles were converted into US dollars (US$) with the appropriate exchange rate for the respective cost year. Costs were adjusted for inflation by using the average consumer price index 20 for each country and purchasing power parity 21 for the year 2015 to enable comparability. When information for cost year was missing, the year of the data collection was as assumed to be the cost year.
RESULTS
A total of 5,570 publications were identified, and after scanning titles/abstracts, 5,298 publications were excluded due to not meeting the inclusion criteria (not chronic wounds, no generic HRQoL data or no cost data). After adding two articles from manual searches, 274 articles were viewed in fulltext, of which 244 did not meet the inclusion criteria. Finally, 30 articles (one article presented both HRQoL and costs data) were included in the systematic review (Figure 1 ).
In the included articles, 16 labeled the wound as chronic or hard-to-heal, and five studies stated a wound duration longer than 3 weeks, but did not label the wounds chronic/ hard-to-heal. Eight studies assessed amputations, and one study presented both chronic wounds and amputations.
The majority of the included HRQoL articles (n = 17) presented acceptable sample sizes for HRQoL studies. 22 However, methods for sampling were often based on convenience or poorly described. Seven articles had appropriate sampling methods and most studies (n = 18) described study participants and settings in detail, and measured HRQoL by validated methods. With regard to the Drummond and Jefferson's Checklist, several nonapplicable items for cost-ofillness evaluations were excluded in the quality assessment. All included cost studies stated the research question (n = 11), most studies presented the economic importance of the study (n = 10), few studies presented details of study participants (n = 3), and only one study discussed the productivity impact. More than half of the studies presented the quantity of resource use separated from the unit costs (n = 7), most studies provided currency and price data (n = 9), and approximately half of the studies presented details of currency and price adjustments for inflation conversions (n = 5). Eight studies stated a time horizon for costs, one study incorporated discounting, and no study justified the choice of discount rate nor gave an explanation for nondiscounted costs. A sensitivity analysis was presented in only one study. The majority of studies answered their research question (n = 10) and all studies provided a conclusion ( Table 1) .
The HRQoL articles consisted of nine cross-sectional studies, six case-control studies, two observational studies, one quasi-experimental study, and one study assessed a measurement tool for HRQoL and one pilot study. Two studies (using SF-36 and EQ-5D) failed to report standardized domain scores which impeded comparability to other studies applying the same instrument. 23, 24 In one study, only wound duration-specific subgroup data could be extracted due to lack of information about chronicity for the rest of the sample (mixed wounds of unknown duration). 25 Nine different instruments were used to measure HRQoL (five studies used more than one instrument). SF-36, the most frequently used instrument was used in half of the studies.
Six studies presented aggregated utility values from different HRQoL instruments; Nottingham Health Profile (NHP), 26 SF-36, 25 EQ-5D, 27 Ferran's and Power's Quality of Life Index, 28 EQ-5D Visual Analogue Scale (VAS), 27, 29 WHOQOL-bref., 30 and numerical rating scale. 27 One study evaluated a disease-specific instrument for patients with chronic wounds by comparing domain scores from three different HRQoL tools. 27 Patients with chronic wounds most frequently reported lower HRQoL scores in the domains related to physical pathologies, i.e., role physical, physical functioning, equivalent to mobility, and/or the physical summary component. 26, [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] The similar and comparable domains, vitality (SF-36) and energy (NHP), 32 also presented inferior scores for patients with chronic wounds. 26, 34, 35, 39, 41 For emotional-and mental health domains, four studies reported lower HRQoL scores for patients with chronic wounds, 31, 35, 36, 40 while five studies did not find any statistical difference when compared to controls. 34, [37] [38] [39] 42 Four studies with control groups reported significantly lower scores for patients with chronic wounds in the domains of bodily pain and pain/discomfort. 26, 35, 39, 40 Eight studies were homogeneous enough to enable calculations of pooled estimates of HRQoL for patients with chronic wounds and amputations (Table 2) . [33] [34] [35] [36] [39] [40] [41] 43 The estimates showed that patients with amputation had inferior scores in most domains, except for the domain role physical, pain and social function where patients with chronic wounds had lower scores. Furthermore, in the subgroup analysis, five studies incorporated patients with chronic wounds and control groups. The box plots (n = 5 showed lower mean scores for chronic wound patients in all SF-36 domains when compared to the control groups. (Supporting Information Figure S1 ). However, these scores should be interpreted with caution due to small sample sizes, large differences in study designs, and heterogeneity in participant characteristics (Figure 2 ).
Long wound duration and/or large wound size were correlated to poorer HRQoL scores in three studies. 25, 37, 40 Three studies specifically assessed pain and HRQoL for patients with chronic wounds, and showed that patients with chronic wounds and severe pain reported even lower HRQoL in several domains compared to patients with wounds experiencing less pain. 24, 30, 31 One study compared patients with amputation and patients with chronic wounds, with significantly poorer scores in the domain bodily pain presented for the latter. 33 An association between pain and lower HRQoL was also found in two other studies reporting improvements in the domain bodily pain and subsequent increases in overall HRQoL after wound healing for patients with chronic wounds. 29, 40 None of the included HRQoL studies addressed or assessed the caregivers' perspective and their HRQoL (Table 3) .
Eleven cost-of-illness studies assessing patients with chronic wounds were found for the cost data. Participants (28) 62 (18) 33 (17) 35 (18) 59 (14) 53 (19) 62 (9) 63 (42) Minor amputations 19 58 (39) 55 (29) 75 (26) 39 (18) 46 (20) 69 (26) 61 (19) 61 (46) Major amputations 6 33 (34) 35 (39) 84 (20) 54 (20) 55 (22) 62 (25) 65 (21) 33 (42) Chase et al. The burden of chronic wounds Olsson et al.
were identified through hospital-and patient records, Diagnosis-related group codes, International Classification of Diseases (ICD) codes, health insurance companies, wound clinics, and national disease-specific registers. The study settings captured costs from inpatient, outpatient, community, and primary care perspectives, e.g., hospitals, wound centers, and foot care teams. [44] [45] [46] Cost data in this section were converted into annual costs when possible to enable a better overview.
Diabetes-related amputations reported the largest proportion of costs for chronic wounds, 38, 45, 47, 48 a cost largely associated with additional inpatient days when hospitalized compared to nondiabetic patients. 45, 48 Cost for hospitalization for diabetesrelated amputations ranged from US$12,851 49 to US$16,267 47 (median) per patient admitted. Davis et al. 49 estimated that 9.3% of the total cost for diabetes-related hospital admissions was related to amputations. One study presented diabetesrelated amputation costs from a societal perspective, including both direct-and indirect costs, estimated at US$33,499 in year 2002 (total annual cost per patient). 38 Long treatment times after amputation, e.g., rehabilitation, outpatient costs, and other additional long-term care also contributed to substantial costs related to amputations. 38, 48 Cost for leg ulcers were assessed in five studies in primary care, outpatient, and community settings (one study covered both in-and outpatient settings). Leg ulcers presented considerably lower costs than amputations, with costs that ranged from US$449 50 to US$2,307 51 annually per patient for primary-and outpatient care, and between US$13,334 46 and 13,761 44 from a societal perspective. Wound treatment costs (e.g., medical equipment and consumables) were considerable for chronic wound management across all study settings. 38, 44, 48, 50 One study compared wound treatment costs for in-and outpatients in hospital settings, and reported no difference for the cost for wound treatment, but detected a lower cost for consumables for the nonhospitalized patients. 52 Large ulcer size, and more severe ulceration 38, 44, 50 with subsequent longer treatment duration (>6 months) (nurse visits for wound dressings and drug prescriptions from physicians, e.g., analgesics and antibiotics), 44, 50, 51 were associated with higher costs. Two studies presented more than doubled costs for patients having larger and more than one wound, when compared to smaller ulcers with shorter healing times. 44, 50 Having several chronic wounds was found to be more cost enlarging due to longer work time for nurses and the utilization of more wound care products. 38, 44 Pain severity was another cost-contributing factor related to an increased consumption of analgesics for pain management. 46 One large study assessing costs for chronic wounds from a Medicaid service claim database concluded that hospitalization made up the larger proportion compared to physician visits and prescription costs. 53 Three studies assessed indirect costs, 38, 44, 46 and reported costs for early retirement, 38, 44 temporary work disability, 38, 44 and productivity losses due to wound dressings (but failed to describe how this was assessed). 46 The latter study also assessed but did not calculate or report costs for the patients' productivity losses because "only a few participants in the study were still working." 46 
DISCUSSION
This systematic review attempted to have a clear definition for chronicity of wounds even though there is no preestablished consensus, to ensure the inclusion of only chronic wounds. The review reveals a poorer HRQoL for patients with chronic wounds, and that wound-related costs are considerable. The inferior HRQoL observed for patients with chronic wounds is worst for physical pathologies, and is similar or markedly lower in some HRQoL domains when compared to other chronic conditions, e.g., chronic obstructive pulmonary disease and cardiovascular diseases. 54, 55 Pain and reduced mobility were reported as the main problem areas for patients with wounds, which underlines the urgent need for improvements in those domains to alleviate the most negative impacts of the condition. 56 It should also be noted that HRQoL may differ between participants due to what wound treatment patients received, if any additional complications were present as well as the current stage of the wound healing trajectory. For example, decreases in HRQoL are often associated with an advancement in the severity of the wound. 38 No publication assessing HRQoL for informal caregivers of patients with chronic wounds was identified in the review, impeding a more comprehensive exploration of the humanistic and economic burden of chronic wounds.
For costs, diabetes-related amputations presented the greatest costs. These were attributed to lengthy hospital stays and long-term costs, e.g., rehabilitation and outpatient treatments. In comparison to patients admitted for heart failure, the median cost per hospitalization were larger for diabetes-related amputations (US$12,851-US$16,267 vs. US$10,454 for heart failure), 57 indicating that amputation costs are similar to other major public health scourges. The substantial cost for diabetes-related amputations shows the importance of preventing chronic wounds from developing into a severe state where amputation is unavoidable. Previous research suggests that cost-saving preventions for amputations should be early and incorporate a comprehensive wound management strategy. 58 Appropriate interventions and management for wounds can lower the risk of amputation by 47-72% depending on strategy (e.g., education, multidisciplinary approaches, wound monitoring, vascular surgery interventions, and the use of therapeutic foot wear) [58] [59] [60] with cost reductions from US$85,000 up to US$1,100,000 per year and intervention. 59 The review revealed that costs for leg ulcers were lower than for amputations and predominantly related to community-and primary care. Although presenting lower costs than amputations, the cost for leg ulcers will accelerate when wounds persist for many years. The work time of nurses and costs for dressing materials are considered the main cost causative components for leg ulcers, which suggests that reduced working time and dressing frequencies would lower costs for leg ulcers. 61 This could be achieved by early detection of changes in the wound that result in worsening conditions, and subsequently providing prompt treatment before the wound requires more extensive care. 58 To enable timely identification of such changes in wounds, extended wound monitoring is fundamental, while to avoid adding costs for nurses work time, technology-based interventions such as telemonitoring could be a solution. 62 Other preventive and cost-effective treatments for leg ulcers when the underlying cause is venous insufficiency are compression therapies 63, 64 and vascular surgery. 64 Few articles in the current review addressed indirect costs. A plausible reason for this might be that chronic wounds often occur in patients above retirement ages. 44 However, a previous study reported substantial indirect costs related to work absenteeism among patients with wounds. 65 Hence, capturing indirect costs are important to comprehensively assess the economic burden of chronic wounds.
Several studies assessed for eligibility in the review failed to specify wound chronicity and were therefore excluded, e.g., pressure ulcers were only labeled as "chronic" in one of the included articles because this wound type is more commonly referred to in terms of stages of tissue loss. Introducing a specified duration/label for inclusion may have excluded relevant articles, but at the same time this approach ensured that included article were in fact focused on chronic wounds, which adds to the robustness of the findings. Including only articles in English, as well as the overrepresentation of articles from European countries, may have resulted in a reduced generalizability of the findings. Characteristics of study populations were not always clearly stated which is an important aspect given that the patients often were recruited from rather homogeneous settings, e.g., clinics, hospitals which also affects the generalizability. Furthermore, the participants were predominantly over 60 years of age, which possibly caused a lower HRQoL related to decreased mobility and increased probability of being comorbid in older ages. However, the risk of developing chronic ulcers increases with age hence reflects the target study population.
For the economic burden of leg ulcers, comparing costs for ulcers of vascular and arterial etiologies would have been valuable, but no cost study differentiated between ulcers of vascular and arterial etiologies, prohibiting comparisons.
Large variations across the studies collecting data for HRQoL (different instruments used) and variations in the costs being assessed impeded larger scale pooled estimates for HRQoL and feasible cost comparisons. It can be argued that including only generic HRQoL into this systematic review may have captured the impact of chronic wounds on HRQoL less adequately due to common comorbidities in this patient population. 66 However, information on HRQoL based on data collected by condition-specific tools prevents comparisons of HRQoL across diseases which is important for decisions that concern resource allocation. 66 Methodological discrepancies for cost articles comprised wounds of various etiology and severity levels being assessed (with subsequently different treatments), further complicated by assorted cost categories and costperspectives being applied. Inconsistency of evidence can also be attributed to the lack of sensitivity analyses to account for the degree of uncertainty of cost valuations (only conducted in one study), lack of presentation of detailed cost data, variation in study design and valuations of unit costs as well as costs being reported from different healthcare systems in various countries making it difficult to conduct feasible cost comparisons. For example, multiple studies did not present the sources of where data for unit costs were retrieved, and some studies assumed that all health care utilization was related to the wound treatment. This is most likely not the case because participants may suffer from other comorbidities. Moreover, most studies presented patients with chronic wounds without a comparison group, thus making it difficult to understand the burden of chronic wounds in relation to healthy individuals and other patient groups.
In conclusion, patients with chronic wounds report low HRQoL and the condition imposes a substantial economic burden. To improve HRQoL and reduce costs for this patient group, better wound care management must be implemented. This study also detected a lack of published HRQoL data for the caregivers of patients with chronic wounds, and notes that only a few cost studies included indirect costs. Future studies need to assess HRQoL of informal caregivers and capture productivity losses for patients with chronic wounds to comprehensively estimate the economic burden from a societal perspective.
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